Barr, Teva to Launch Generic Allegra Versions
From Associated Press
Barr Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. said they would cooperate in launching generic versions of Sanofi-Aventis’ Allegra allergy drug.
Barr of Pomona, N.Y., received final approval last week for the generic drug from the Food and Drug Administration.
Allegra sales were worth $1.4 billion for the 12 months ended in June, according to research firm IMS Health.
